Extravasation Management
Inject 2 ml of the sodium thiosulfate solution for each milligram of mechlorethamine suspected to have extravasated. Inject the solution subcutaneously into the extravasation site using a 25 …
Vesicant Chemotherapy Extravasation Antidotes and Treatments
This article describes manufacturers' recommendations, lists antidotes and treatments approved by the FDA, and reviews published guidelines and recommendations. Available antidote and treatment formulations and their preparation and administration also are discussed.
Extravasation/Infiltration Management Chart - Johns Hopkins University ... VinCRIStine*
If more than the recommended time has passed for when to give the antidote, it is still recommended that it be administered, although efficacy may be compromised
Vesicant & irritant chemotherapy - HemOnc.org
Vesicant: Medication that may causes severe and/or irreversible tissue injury and necrosis. Irritant: Medication that can cause local inflammatory reactions at the infusion site, which may include: burning, swelling, pain, inflammation, tightness, or phlebitis.
Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN nal policies to manage vesicant chemotherapy extravasations. Antidote and treatment recommendations of vesicant chemotherapy manufacturers, antidotes and treatments approved by the U.S. Food and Drug Administration (FDA), and guidelines and recommendations made by professional
Journal of Infusion Nursing - LWW
For pH-mediated, osmolarity-mediated, and absorption refractory extravasations, the goal is to dilute the vesicant through absorption and dispersal, so the appropriate antidote is hyaluronidase.
Vesicant Chemotherapy Extravasation Antidotes and Treatments
2009年9月1日 · Antidote and treatment recommendations of vesicant chemotherapy manufacturers, antidotes and treatments approved by the U.S. Food and Drug Administration (FDA), and guidelines and...
Examples of agents with irritant and vesicant potential include, but are not limited to: anti-neoplastics such as cisplatin, doxorubicin, and vincristine and non-anti-neoplastics such as phenergan, potassium chloride, and vancomycin. Prevention and early recognition remain the ideal management for extravasation injuries.
(PDF) Recommendations for Management of Noncytotoxic Vesicant ...
2020年11月1日 · To prepare clinicians to treat extravasation of noncytotoxic vesicants with antidotes and thermal compresses, a literature review was performed to identify noncytotoxic vesicants and to create...